Myopotential oversensing in implantable defibrillators causing inhibition of pacing and inappropriate therapies is well described. Current literature is dominated by reports of diaphragmatic muscle as the source of such far-field oversensing. Those reporting pectoral muscle sources were invariably due to unipolar sensing circuits, incorrect DF-1 connections or inappropriate programming. We report an interesting case of pectoral muscle myopotential oversensing causing inhibition of bradycardia pacing leading to presyncope and syncope.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572022 | PMC |
Heart Rhythm
September 2024
Cardiology Unit, Luigi Sacco University Hospital, Milan, Italy.
JACC Clin Electrophysiol
August 2024
King's College Hospital, London, United Kingdom.
Background: The extravascular (EV) implantable cardioverter-defibrillator (ICD) includes features to address sensing and arrhythmia detection challenges presented by its substernal lead location.
Objectives: In this study, the authors sought to evaluate sensing and detection performance in 299 patients discharged with an EV-ICD in the global pivotal study.
Methods: We reviewed and adjudicated all induced ventricular fibrillation (VF) episodes and spontaneous device-stored episodes that satisfied rate and duration criteria in a programmed ventricular tachycardia (VT)/VF therapy zone.
Int J Cardiol
July 2023
Division of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
HeartRhythm Case Rep
February 2023
Department of Medicine, University of British Columbia, Vancouver, Canada.
HeartRhythm Case Rep
September 2021
Department of Cardiology, Leeds General Infirmary, Leeds, United Kingdom.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!